glp 1 compound companies versions of GLP-1 drugs for weight loss halted by FDA Compounding of GLP-1 Drugs |

GLP-1 side effects include gastrointestinal complications, such as nausea, vomiting, diarrhea, constipation, and diverticulitis

Semaglutide is a GLP-1 receptor agonist that primarily acts on receptors in the brain (appetite regulation), pancreas (insulin secretion), and gastrointestinal tract (gastric emptying)

Wonki K, Kim JA, Lee SH, Bae S, Choi IY, Kim YH

Currently, most of the people who have filed Ozempic lawsuits did so because they suffered severe stomach side effects, such as gastroparesis, ileus or intestinal blockage

The market is expected to grow from $65,865.6 million in 2025 to $139,268.4 million in 2030 at a rate of 16.2%

Counter (Macrofy Inc) has set a new standard in this category